• Blog
  • Global Pneumonia Vaccines Market

    Global Pneumonia Vaccines Market

    Global Pneumonia Vaccines Market
    Report code - SRHL186 Delivery - 2 Weeks
    Global Pneumonia Vaccines Market Size, Share, Trend, Forecast, & Industry Analysis: 20 See more...

    Market Insights

    Global Pneumonia Vaccines Market is likely to witness an impressive CAGR of 5.0% during the forecast period. 

    To know more about the market trends, Register here.

    What are pneumonia vaccines?

    Pneumonia is a disease that causes lung contamination by a bacterial or viral infection of the air sacs in one or both of the lungs and is commonly found in adults. 
     

    Global Pneumonia Vaccines Market Report Overview

    Market Size in 2025

    USD X.XX Billion

    Market Size in 2020

    USD X.XX Billion

    Market Growth (2020-2025)

    CAGR of 5.0%

    Base Year of Study

    2019

    Trend Period

    2015-2018

    Forecast Period

    2020-2025

    Market Drivers

    • The growing prevalence of chronic diseases such as chronic obstructive pulmonary disease, diabetes mellitus, and chronic heart disease, pneumococcal contamination within the population, the introduction of novel pneumococcal vaccine
    • Increasing support of the government in creating awareness about pneumonia immunization programs is one of the major factors accelerating the growth of the market during the forecast period.

    Key players

    Some of the key players in the market are-

    Segment Analysis

    Product Type

    The market is segmented into pneumonia conjugate vaccines and pneumonia polysaccharide vaccines. The pneumonia conjugate vaccine is estimated to be the largest product type in the market owing to its ability to immunize infants and children from the age of 6 weeks to 5 years, providing prevention from invasive disease, pneumonia, and acute otitis media.

    There has been an increase in the adoption and usage of pneumonia conjugate vaccines amongst the population as many people are vulnerable to pneumonia including children below 5 years and adults above 50 years as well.

    On the contrary, the pneumonia polysaccharide vaccine is estimated to be the fastest-growing segment in the market. The growth is attributed to the Pneumovax 23 which has been proven very effective in protecting healthy young adults from invasive pneumonia disease, fueling the product demand during the forecast period.

     By Region

    Asia-Pacific is leading the market with India being the major country witnessing a significant growth rate, attributed to the increasing prevalence of pneumonia and growing mortality associated with the disease which is expected to fuel the product demand during the forecast period.

    Further, the government getting strong funds from the Global Alliance of Vaccines and Immunization for more accessible pneumonia vaccines and increasing affordability will accelerate the growth of the regional market over the forecast period. North America and Europe are also expected to offer substantial growth opportunities during the forecast period.

    To get more information about this report, register here.

    Segmentation   

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The market is segmented into the following categories. 

     By Product Type:

    • Pneumonia Conjugate Vaccines 
    • Pneumonia Saccharide Vaccines 

     By Region:

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    To understand more about this segment trend, register here.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with companies across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    in-depth analysis of the pneumonia vaccines market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    What are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the product types by region type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    Pneumonia is a disease that causes lung contamination by a bacterial or viral infection of the air sacs in one or both of the lungs, and is commonly found in adults.

    GlaxoSmithKline Plc., LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Bioscience, and Walvax Biotechnology Co., Ltd are among the key players in the pneumonia vaccine market.

    Asia-Pacific is leading the pneumonia vaccine market with India being the major country witnessing significant growth rate.

    The pneumonia conjugate vaccine is estimated to be the larger product type in the pneumonia vaccine market in the coming years.

    The Global Pneumonia Vaccines Market is likely to witness an impressive CAGR of 5.0% in 2020-25.

    The growing prevalence of chronic diseases such as chronic obstructive pulmonary disease, diabetes mellitus and chronic heart disease, pneumococcal contamination within the population, the introduction of novel pneumococcal vaccine Increasing support of the government in creating awareness about pneumonia immunization programs is some of the major factors accelerating the growth of the market during the forecast period.

    The study period of this market report is 2020-25.